A one-stop-shop CRO bringing together innovative platforms, strategic solutions and specialized expertise to drive drug development and advance diverse fields of research.
Policies, Terms & Conditions
We are excited to announce an upcoming webinar in collaboration with SPT Labtech, titled “Advanced Proteomic Biomarker Discovery for Understanding Disease Pathophysiology”, which will provide cutting-edge insights into how next-generation proteomics can transform your research.
SPT Labtech is a leading provider of innovative solutions for liquid handling, sample management, and data generation in the life sciences. Their instruments are designed to streamline and enhance laboratory workflows, enabling scientists to generate high-quality data with greater accuracy and efficiency.
In the fast-evolving field of biomedical research, the ability to accurately discover and validate biomarkers is essential for improving diagnostics, prognostics, and treatment strategies. This webinar will delve into the latest advancements in proteomic technologies and multi-omics approaches that are pushing the boundaries of what’s possible in disease research.
Here’s what you can expect to learn from our experts:
- How next-generation proteomics, combined with multi-omics approaches, can be leveraged to identify and validate key biomarkers and significantly improve diagnostics, prognostics, and treatment strategies across a range of diseases.
- How the integration of Olink® Explore technology with SPT Labtech instruments is revolutionizing the generation of high-quality proteomic data.
– Date: Wednesday, September 25, 2024
– Time: 16:00 BST / 17:00 CEST / 11:00 EDT / 8:00 PDT
– Registration: Proteomic biomarker discovery for understanding disease pathophysiology (selectscience.net)
This is a unique opportunity to stay at the forefront of proteomic research and learn how cutting-edge technologies from Olink and SPT Labtech can enhance your research capabilities.
Register now to secure your spot and join us for an insightful session that promises to advance your understanding of disease pathophysiology.
Latest posts
Firalis Molecular Precision is now Precursion 15.06.26 Huningue, France, 15/06/2026 – Firalis Molecular Precision, a company specializing in biomarkers and multi-omics analysis for precision medicine...
Firalis Molecular Precision is excited to be a part of Biomarkers US 2024 in San Diego on October 28-29. As a provider of bioanalytical solutions, we’ll be discussing how our biobanking, bioanalytical...
We are pleased to announce an upcoming webinar in collaboration with Olink, Part of Thermo Fisher, titled “Detecting Alzheimer’s Disease Subtypes with Serum Proteomics”, showcasing how advanced...
Share this article on your socials